SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-330590
Filing Date
2020-12-31
Accepted
2020-12-31 16:03:38
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 d48040ds3.htm S-3 198349
2 EX-5.1 d48040dex51.htm EX-5.1 8628
3 EX-23.1 d48040dex231.htm EX-23.1 1631
4 GRAPHIC g48040g05h66.jpg GRAPHIC 40046
5 GRAPHIC g48040g58i59.jpg GRAPHIC 9909
  Complete submission text file 0001193125-20-330590.txt   273297
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251853 | Film No.: 201428883
SIC: 2834 Pharmaceutical Preparations